2m 2m 2m 2m 2m 2m 2m
RXSIGHT (RXST)
NASDAQ
$4.92-$0.03 (-0.51%)
Price as of Jun 03, 2026 5:48 PM EDT- $220.6MMarket Cap
- -68.75%1-Year Change
- Medical DevicesIndustry
RXSIGHT (RXST)
$4.92-$0.03 (-0.51%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 134.5M -3.89% | 139.9M +57.09% | 89.1M +81.77% | 49.0M +116.90% | |
Cost of Revenue | 31.5M -23.21% | 41.0M +16.06% | 35.3M +27.59% | 27.7M +53.11% | |
Gross Profit | 103.0M +4.11% | 98.9M +84.03% | 53.8M +152.09% | 21.3M +372.17% | |
Sales and Marketing Expense | 112.7M +11.06% | 101.4M +35.61% | 74.8M +27.50% | 58.7M +78.83% | |
Research and Development Expense | -38.5M +12.17% | -34.4M +18.30% | -29.1M +11.82% | -26.0M +6.05% | |
Depreciation and Amortization Expense | 3.3M -8.64% | 3.6M -12.33% | 4.1M +4.99% | 3.9M -2.29% | |
Total Operating Expenses | 151.2M +11.34% | 135.8M +30.77% | 103.8M +22.69% | 84.6M +47.71% | |
Operating Profit | -48.2M +30.75% | -36.9M -26.41% | -50.1M -20.90% | -63.3M +19.95% | |
Interest Income | 9.3M -1.50% | 9.5M +44.11% | 6.6M +333.36% | 1.5M +2,709.26% | |
Interest Expense | -19,000 -9.52% | -21,000 -99.37% | -3.3M -33.12% | -4.9M +34.33% | |
Interest Income and Expense and Net | 9.3M -1.48% | 9.5M +189.44% | 3.3M +195.25% | -3.4M -5.49% | |
Total Nonoperating Income and Expense | 19,000 -9.52% | 21,000 -99.37% | 3.3M -33.12% | 4.9M +34.33% | |
Income before Taxes | -38.9M +41.86% | -27.4M -43.60% | -48.6M -27.21% | -66.7M +37.11% | |
Income Taxes | 66,000 +32.00% | 50,000 +150.00% | 20,000 +122.22% | 9,000 +12.50% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -38.9M +41.85% | -27.5M -43.52% | -48.6M -27.19% | -66.8M +37.11% | |
Net Income from Continuing Operations Applicable to Common | -38.9M +41.86% | -27.4M -43.60% | -48.6M -27.21% | -66.7M +37.09% | |
Basic EPS and Net Income | -0.95 +33.80% | -0.71 -49.65% | -1.41 -41.49% | -2.41 -32.49% | |
Diluted EPS and Net Income | -0.95 +33.80% | -0.71 -49.65% | -1.41 -41.49% | -2.41 -32.49% | |
Basic Weighted Average Shares | 40.9M +5.10% | 38.9M +12.81% | 34.5M +24.56% | 27.7M +103.02% | |
Diluted Weighted Average Shares | 40.9M +5.10% | 38.9M +12.81% | 34.5M +24.56% | 27.7M +103.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 19.9M +19.41% | 16.7M +72.37% | 9.7M -18.10% | 11.8M -51.42% | |
Short-Term Investments | 208.2M -5.60% | 220.5M +87.69% | 117.5M +25.03% | 94.0M -30.38% | |
Cash and Cash Equivalents and Short-Term Investments | 228.1M -3.83% | 237.2M +86.52% | 127.2M +20.21% | 105.8M -33.60% | |
Total Current Assets | 287.5M -2.17% | 293.8M +74.47% | 168.4M +25.16% | 134.6M -23.68% | |
Accumulated Depreciation | 26.6M +4.48% | 25.4M +12.03% | 22.7M +14.07% | 19.9M +21.74% | |
Property and Plant and Equipment and Net | 13.1M +5.18% | 12.4M +14.50% | 10.8M +6.93% | 10.1M -9.62% | |
Total Long-Term Assets | 590,000 +63.89% | 360,000 +144.90% | 147,000 -80.83% | 767,000 +572.81% | |
Total Assets | 311.8M -2.12% | 318.6M +74.51% | 182.6M +21.57% | 150.2M -22.08% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 200,000 -23.08% | 260,000 -16.13% | |
Total Current Liabilities | 26.3M +1.46% | 25.9M +23.79% | 20.9M +21.27% | 17.2M +55.61% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 40.2M +1.03% | |
Total Long-Term Liabilities | 0 -100.00% | 127,000 +71.62% | 74,000 -99.82% | 40.2M +1.03% | |
Total Liabilities | 36.1M -3.20% | 37.3M +68.22% | 22.2M -63.18% | 60.3M +10.62% | |
Retained Earnings | -661.0M +6.26% | -622.1M +4.62% | -594.6M +8.90% | -546.0M +13.93% | |
Total Stockholders Equity | 275.7M -1.98% | 281.2M +75.38% | 160.4M +78.37% | 89.9M -34.97% | |
Total Shares Outstanding | 41.2M +2.01% | 40.4M +11.87% | 36.1M +27.84% | 28.3M +3.29% | |
Cash Flow | |||||
Cash from Operating Activities | -15.5M -8.47% | -16.9M -59.26% | -41.6M -29.32% | -58.9M +31.63% | |
Capital Expenditures | 3.8M -29.60% | 5.4M +13.00% | 4.8M +101.17% | 2.4M +23.35% | |
Cash from Investing Activities | 16.9M +117.01% | -99.3M +348.78% | -22.1M -155.39% | 40.0M +148.77% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.9M -98.49% | 123.3M +100.44% | 61.5M +871.64% | 6.3M -95.39% | |
Financials Ratio | |||||
Gross Margin | 76.60% +8.33% | 70.71% +17.15% | 60.36% +38.68% | 43.52% N/A | |
Operating Margin | -35.84% +36.04% | -26.34% -53.15% | -56.23% -56.48% | -129.21% N/A | |
Return on Assets | -12.36% +12.76% | -10.96% -62.50% | -29.22% -24.96% | -38.94% N/A | |
Return on Equity | -13.99% +12.48% | -12.43% -67.99% | -38.85% -33.62% | -58.52% N/A | |
Revenue Growth | -3.89% -106.82% | 57.09% -30.19% | 81.77% -30.05% | 116.90% N/A | |
Current Ratio | 10.95 -3.57% | 11.36 +40.94% | 8.06 +3.21% | 7.81 N/A | |
Cash Ratio | 0.76 +17.70% | 0.65 +39.23% | 0.46 -32.45% | 0.69 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.001 -99.73% | 0.45 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.001 -99.59% | 0.27 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow